Opendata, web and dolomites

AllergyExplorer SIGNED

Automation of novel multi-parameter allergy test that is cost-efficient and delivers instantly correct results

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 AllergyExplorer project word cloud

Explore the words cloud of the AllergyExplorer project. It provides you a very rough idea of what is the project "AllergyExplorer" about.

million    pressure    segments    tested    routine    almost    diagnosed    select    jobs    time    selling    practitioners    century    points    rate    instead    off    forcing    patients    amounted    valuable    adequately    spent    usd    life    bn    expand    fast    close    market    diagnosis    technically    labs    allergen    anamnesis    medical    monopoly    quality    allergic    21st    declared    molecular    public    diagnostics    customers    union    digit    optimal    automated    globally    provides    population    supplier    avoidance    individual    approx    eliminate    700    estimate    least    single    automate    insufficiently    enhanced    recommendations    independent    140    allergens    manual    clearer    de    validated    delivering    multiply    risk    vitro    solution    return    decision    few    health    customer    prior    revenues    substantiates    profile    annual    asthma    saved    trade    quarter    treatment    therapeutic    2016    immunotherapy    100    double    lab    registered    instrumentation    facto    half    allergy    complete    clinical    allergies    global    immunological    device    experts   

Project "AllergyExplorer" data sheet

The following table provides information about the project.

Coordinator
MACROARRAY DIAGNOSTICS GMBH 

Organization address
address: GUTHEIL SCHODER GASSE 17 TECHPARK VIENNA STIEGE 3
city: WIEN
postcode: 1230
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Austria [AT]
 Total cost 3˙536˙250 €
 EC max contribution 2˙475˙375 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2020-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MACROARRAY DIAGNOSTICS GMBH AT (WIEN) coordinator 2˙475˙375.00

Map

 Project objective

Allergies and asthma affect at least a quarter of the population and the WHO has declared allergy a major health problem of the 21st century. Currently, medical practitioners must pre-select very few allergens for in-vitro testing, based on prior anamnesis, under time and cost pressure. Independent experts estimate that almost half of the patients are diagnosed insufficiently. The consequences for the patients are not optimal treatment and reduced quality of life. For the public health systems more than 140 Bn Euro are spent each year which could be saved if all allergic patients were treated adequately. We have developed a multi-parameter allergy test covering close to 100% of the globally relevant allergens in a single lab test. Instead of forcing medical practitioners to pre-select very few allergens for in-vitro, our solution substantiates any therapeutic decision by offering a complete immunological profile for every tested individual. We expand testing to the molecular level which provides valuable decision points such as enhanced risk assessment, improving the success of allergen immunotherapy or clearer recommendations for avoidance. We eliminate the trade-off between cost and quality of allergy diagnosis. Our allergy test is technically validated and registered as an in-vitro diagnostics device in Europe. We are already selling and delivering the non-automated manual test systems to customers all over Europe. In this project, we will fully automate the test instrumentation so we can target the customer segments of highly automated clinical routine labs. This will multiply our selling potential and expand our customer reach. The global market of in-vitro diagnosis of allergy is growing fast at almost double-digit rate globally, and amounted to approx. 700 million USD annual revenues in 2016. There is a de-facto monopoly of a single US supplier and this project will return jobs and revenues to the European Union.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ALLERGYEXPLORER" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ALLERGYEXPLORER" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DetectInMen (2019)

Infection detection in human semen

Read More  

ADAPTOS (2019)

ADAPTOS - Changing the way bone voids are treated

Read More  

Savesight (2020)

Contact lens embedded sensor for ocular hypertension and glaucoma monitoring

Read More